Advertisement

Author: Alan Condon

Atlanta-based Piedmont Healthcare has opened a neurosciences services line that has allowed the 11-hospital health system to invest in spine, brain tumor and cerebrovascular care, the Henry Herald reported April 26.

DiscGenics, a biopharmaceutical company focused on regenerative therapies for spinal conditions, has finished enrolling patients in its Japanese study of  IDCT, an allogeneic, injectable disc cell therapy for lumbar disc degeneration.

Spine surgeons investing in surgery centers have the potential to realize significant profit in the coming years as procedures continue to shift from inpatient to outpatient settings.

Advertisement
Advertisement